We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Melatonin Levels in Parkinson’s Patients Linked to Non-Motor Symptoms

By LabMedica International staff writers
Posted on 21 Jul 2020
Parkinson’s disease (PD) is a complex neurodegenerative disease characterized by the loss of dopaminergic neurons in the pars compacta (SNpc), resulting in the classic motor manifestations in PD patients. More...
The clinical diagnosis of PD mainly relies on the presence of motor symptoms as the disease progresses.

Melatonin is a hormone produced by the pineal gland, a small pea-shaped gland in the brain that regulates sleep. Higher levels of this hormone are usually present at night. In addition to its main role in regulating the circadian rhythm, melatonin also controls the production of other hormones, helps regulate the body’s internal temperature, and influences cognitive performance and mood.

Neurologists at the Henan Provincial People’s Hospital (Zhengzhou, China) explored the possible relationship between melatonin levels and non-motor symptoms of Parkinson’s, and measured the levels of melatonin circulating in the blood of 61 patients with Parkinson’s (average age 62.4 years) and 58 age and sex-matched healthy individuals (controls). Within the Parkinson’s group, 14 patients had cardiovascular symptoms (23%), 42 had gastrointestinal dysfunction (68.9%) and 51 had sleep disorders (83.6%).

Blood samples were collected in the dark, or under a dim light, following a 12-hour overnight fasting period in all study participants. Melatonin levels were determined by enzyme-linked immunosorbent assay (ELISA, Shanghai Blue Gene Biotech, Co. Ltd., Shanghai, China), which has the following characteristics: sensitivity, 1.0 pg/mL; intra-assay coefficient of variation, < 9%; and interassay variation coefficient of variation, < 10%. All samples were analyzed in triplicate and averaged.

The scientists reported that compared with the healthy controls, the plasma melatonin levels were significantly higher in PD patients (12.82 ± 4.85 versus 19.40 ± 4.23). Higher plasma melatonin concentrations were detected in the negative cardiovascular symptom group than in the cardiovascular symptom group and higher plasma melatonin concentrations were detected in the non-sleep-disorders group than in the sleep disorders group. In addition, the plasma melatonin concentration was higher in the group without gastrointestinal dysfunction than in the gastrointestinal dysfunction group.

The authors concluded that the plasma melatonin levels in PD patients were significantly higher than those in healthy controls. Non-motor symptoms that were significantly negatively correlated with plasma melatonin levels were cardiovascular symptoms, sleep disorders, and gastrointestinal dysfunction. Plasma melatonin levels have the closest relationship with sleep disorders. There was a correlation between plasma melatonin levels and sleep quality in patients with PD. The remaining non-motor symptoms were not related to plasma melatonin levels. The study was originally published online on May 19, 2020 in the journal Frontiers in Neuroscience.

Related Links:
Henan Provincial People’s Hospital
Shanghai Blue Gene Biotech



Gold Member
Troponin T QC
Troponin T Quality Control
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Gold Member
Latex Test
SLE-Latex Test
New
Vasculitis Diagnostic Test
AESKULISA Vasculitis-Screen
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The POC device rapidly predicts neonatal respiratory disease at birth in the NICU (Photo courtesy of SIME Diagnostics)

AI-Powered Lung Maturity Test Identifies Newborns at Higher Risk of Respiratory Distress

Each year, approximately 300,000 babies in the United States are born between 32 and 36 weeks' gestation, according to national health data. This group is at an elevated risk for respiratory distress,... Read more

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Pathology

view channel
Image: A biomarker discovery pipeline has shown promise as a noninvasive method of diagnosing CRC (Photo courtesy of NCI Center for Cancer Research)

Machine Learning Tool Enables Noninvasive Diagnosis and Monitoring of Colorectal Cancer

Colorectal cancer (CRC) is the second leading cause of cancer-related deaths in the United States when considering both genders. Colonoscopy remains the gold standard for CRC diagnosis, but it is invasive,... Read more

Technology

view channel
Image: Scanning electron microscopy images showing 3D micro-printed Limacon-shaped whispering-gallery-mode microcavities with different amounts of deformation (Photo courtesy of A. Ping Zhang/PolyU)

Tiny Microlaser Sensors with Supercharged Biosensing Ability to Enable Early Disease Diagnosis

Optical whispering-gallery-mode microlaser sensors function by trapping light within tiny microcavities. When target molecules bind to the cavity, they induce subtle changes in the laser’s frequency, allowing... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.